131 – 140 of 165
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2000
-
Mark
ErbB2 status and the benefit from two or five years of adjuvant tamoxifen in postmenopausal early stage breast cancer
2000) In Annals of oncology : official journal of the European Society for Medical Oncology 11(12). p.1545-1550(
- Contribution to journal › Article
- 1999
-
Mark
Immunologic proliferation marker Ki-S2 as prognostic indicator for lymph node-negative breast cancer
(
- Contribution to journal › Article
-
Mark
Regression of intracerebral rat glioma isografts by therapeutic subcutaneous immunization with interferon-gamma, interleukin-7, or B7-1-transfected tumor cells
(
- Contribution to journal › Article
-
Mark
Preanalytical requirements for flow cytometric evaluation of platelet activation : Choice of anticoagulant
(
- Contribution to journal › Article
- 1998
-
Mark
Distribution of non-diploid flow-cytometric DNA indices and their relation to the nodal metastasis in squamous cell carcinomas of the head and neck
(
- Contribution to journal › Article
-
Mark
Comparison of different labelling index formulae used on bromodeoxyuridine-flow cytometry data
(
- Contribution to journal › Article
-
Mark
S-phase fraction assessed by a variant of the rectangular model adapted to the flow-cytometric DNA histogram profile
(
- Contribution to journal › Letter
-
Mark
Different calculation methods for flow cytometric S-phase fraction: prognostic implications in breast cancer? The Swedish Society of Cancer Study Group
(
- Contribution to journal › Article
-
Mark
Reduced expression of C5a receptors on neutrophils from cord blood
(
- Contribution to journal › Article
- 1997
-
Mark
Flow cytometric S-phase fraction in soft-tissue sarcoma: prognostic importance analysed in 160 patients
(
- Contribution to journal › Article